Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Spain Court Backs Ruling for German Firm in Thalidomide Case

September 24, 2015 10:02 am | by The Associated Press | News | Comments

Spain's Supreme Court has upheld a lower court ruling that a German pharmaceutical company does not have to pay compensation to 22 Spaniards who blame their disabilities on the drug thalidomide. Read more...


Roche Gains FDA CLIA Waiver for Flu A/B Test for Cobas Liat PCR System

September 24, 2015 9:56 am | News | Comments

An estimated three to five million individuals develop influenza each year worldwide. Read more...


We Need a New Golden Age of Antibiotics

September 24, 2015 9:43 am | by Alice Erwin, microbiologist, and scientific consultant with InnovaTID | Articles | Comments

In the race between resistant bacteria and the drugs that can treat them, humanity is losing ground.  Antibiotics are rapidly losing their effectiveness as microbes evolve to resist them. As the United Kingdom’s Chief Medical Officer Professor Dame Sally Davies has said, “We have reached a critical point and must act now on a global scale to slow down antimicrobial resistance.” Read more...


Identifying the 'Dimmer Switch' of Diabetes

September 24, 2015 7:45 am | by University of Alberta | News | Comments

The dimmer appears to be lost in Type 2 diabetes but can be restored and ‘turned back on’. Read more...


Enlisting Viruses

September 24, 2015 7:30 am | by Anne Trafton, MIT News Office | News | Comments

In the hunt for new ways to kill harmful bacteria, scientists have turned to a natural predator: viruses that infect bacteria. Read more...


U.N. Ebola Response Now Planned to Continue Into 2016

September 24, 2015 7:00 am | by Krista Larson, Associated Press | News | Comments

The United Nations is now planning for its Ebola response to last into mid-2016. Read more...


Seeking a Better Way to Design Drugs

September 23, 2015 12:51 pm | by Worcester Polytechnic Institute | News | Comments

The National Institutes of Health (NIH) has awarded $346,000 to Worcester Polytechnic Institute (WPI) for a three-year research project to advance development of a chemical process that could significantly improve the ability to design new pharmaceuticals and streamline the manufacturing of existing drugs. Read more...


Amgen, Allergan: Positive Top-line Results From Phase 3 Study of Biosimilar Candidate

September 23, 2015 12:47 pm | News | Comments

Amgen and Allergan plc. today announced a Phase 3 study of biosimilar candidate ABP 215 met its primary and secondary endpoints. The study evaluated the efficacy and safety of ABP 215 compared with Avastin (bevacizumab) in adult patients with advanced non-squamous non-small cell lung cancer (NSCLC). Read more...


New Cancer Genes Identified, Opening Door to Targeted Treatments

September 23, 2015 12:42 pm | by University of Virginia | News | Comments

In a discovery that could lead to more targeted and effective treatments for certain lung and prostate cancers, researchers at the University of Virginia School of Medicine have identified two new cancer-causing gene mutations – mutations that may be particularly susceptible to cancer-fighting drugs already approved by the federal Food and Drug Administration.  Read more...


Scientists Awarded $6 Million to Develop Alternative HIV/AIDS Vaccine

September 23, 2015 12:36 pm | by The Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded up to nearly $6 million from the Bill & Melinda Gates Foundation to develop a revolutionary HIV/AIDS alternative vaccine that has demonstrated great potential in animal models. Read more...


Clinton Plan to Reduce Drug Costs Gets Shrugs From Industry

September 23, 2015 12:32 pm | by Matthew Perrone, AP Health Writer | News | Comments

Hillary Rodham Clinton's plan to rein in prescription drug prices by reshaping how drugmakers do business is being met by skepticism within the industry. Read more...


Daraprim Price Will Be Lowered, Turing CEO Shkreli Says

September 23, 2015 11:08 am | by Stephanie Guzowski, Editor | News | Comments

After significantly hiking the price of antiparasitic drug Daraprim (pyrimethamine), from $13.50 per pill to $750 — and vehemently defending his company’s right to do so — Turing Pharmaceutical’s CEO Martin Shkreli backed down a bit late Tuesday. Shkreli told TV networks that his company has agreed to lower the price of the drug, Daraprim — but he didn’t specify what the new price would be. Read more...


Scientists Create Immunity to Deadly Parasite by Manipulating Host's Genes

September 23, 2015 8:15 am | by University of Virginia | News | Comments

There are two common approaches to protecting humans from infectious disease. Read more...


FDA Approves Taiho Oncology's MCRC Drug

September 23, 2015 8:00 am | News | Comments

Lonsurf is intended for the treatment of patients with a form metastatic colorectal cancer (mCRC) that is resistant to other forms of treatment. Read more...


Global HIV Therapeutics Market Value Will Crawl to Almost $15.3B by 2023

September 23, 2015 7:45 am | by Moritz Hermann, Ph.D., Analyst, GlobalData | News | Comments

The market growth will mainly be driven by the introduction of novel drugs, such as STRs with improved tolerability, a reduced pill burden or increased efficacy, and an increasing number of people living with HIV who are treated with antiretroviral therapy (ART). Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.